TRINTELLIX® was evaluated based on relief of the overall symptoms of MDD in adults using MADRS or HAM‑D24 total score in six short‑term (6‑ to 8‑week) clinical studies.
TRINTELLIX® is indicated for the treatment of Major Depressive Disorder (MDD) in adults.
Important Safety Information
Warning: Suicidal Thoughts & Behaviors
- Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.
- Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.
- TRINTELLIX is not approved for use in pediatric patients.
Please see Full Prescribing Information.
Did you know you can request TRINTELLIX samples and Savings Cards online?
Yes
No
TRINTELLIX® is indicated for the treatment of Major Depressive Disorder (MDD) in adults.
Important Safety Information
Warning: Suicidal Thoughts & Behaviors
- Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.
- Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.
- TRINTELLIX is not approved for use in pediatric patients.
Please see Full Prescribing Information.
*Only commercially insured patients ages 18 and older are eligible
for the TRINTELLIX Savings Card. See Savings Card for full Eligibility Requirements and Terms & Conditions.
TRINTELLIX® is indicated for the treatment of Major Depressive Disorder (MDD) in adults.
Important Safety Information
Warning: Suicidal Thoughts & Behaviors
- Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.
- Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.
- TRINTELLIX is not approved for use in pediatric patients.
Please see Full Prescribing Information.
Resources to start your patient's TRINTELLIX journey today.
Discover coverageRequest samplesExplore savingsTRINTELLIX® is indicated for the treatment of Major Depressive Disorder (MDD) in adults.
Important Safety Information
Warning: Suicidal Thoughts & Behaviors
- Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.
- Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.
- TRINTELLIX is not approved for use in pediatric patients.
Please see Full Prescribing Information.
